Onfi Suspension
Product Images NDC 67386-313

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Onfi (NDC 67386-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lundbeck Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Onfi-01 (Onfi 1)

FDA Label Image

Onfi-08 (Onfi 10)

FDA Label Image

Onfi-09 (Onfi 11)

FDA Label Image

Onfi-10 (Onfi 12)

FDA Label Image

Onfi-11 (Onfi 13)

FDA Label Image

Onfi-12 (Onfi 14)

FDA Label Image

Logo (Onfi 15)

FDA Label Image

Ndc 67386-314-01 100 Tablets Onfi® (clobazam) Tablets 10 mg C-iv Dispense The Enclosed Medication Guide With Each Prescription. Rx Only (Onfi 16)

FDA Label Image

Ndc 67386-315-01 100 Tablets Onfi® (clobazam) Tablets 20 mg C-iv Dispense The Enclosed Medication Guide With Each Prescription. Rx Only (Onfi 17)

Ndc 67386-315-01 100 Tablets Onfi® (clobazam) Tablets 20 mg C-iv Dispense The Enclosed Medication Guide With Each Prescription. Rx Only (Onfi 17)
This appears to be a label containing information on a medication called "Onfi’ (clobazam) Tablets". The label includes the dosage amount of the drug, but does not provide any additional description or instructions.*
FDA Label Image

Ndc 67386-313-21 120 mL Onfi® (clobazam) Oral Suspension 2.5 mg/ml C-iv For Oral Administration Only. Dispense The Enclosed Medication Guide And Instructions For Use With Each Prescription. Rx Only (Onfi 18)

Ndc 67386-313-21 120 mL Onfi® (clobazam) Oral Suspension 2.5 mg/ml C-iv For Oral Administration Only. Dispense The Enclosed Medication Guide And Instructions For Use With Each Prescription. Rx Only (Onfi 18)
This is a product called Onfi (clobazam) Oral Suspension, which should be used within 90 days of first use. It is a liquid suspension supplied with two 10mL syringes for oral administration only. The enclosed medication should be dispensed for a week along with a guide and instructions for use accompanying each prescription. The text also instructs the user to store and dispense the product in an upright position and to shake the bottle before use.*
FDA Label Image

Onfi-02 (Onfi 2)

FDA Label Image

Onfi-03 (Onfi 3)

FDA Label Image

Logo (Onfi 4)

FDA Label Image

Logo (Onfi 5)

FDA Label Image

Onfi-04 (Onfi 6)

FDA Label Image

Onfi-05 (Onfi 7)

FDA Label Image

Onfi-06 (Onfi 8)

FDA Label Image

Onfi-07 (Onfi 9)

Onfi-07 (Onfi 9)
This text appears to be a brief description of a medical device or instrument. It mentions "Dosage indicators", which could refer to a feature on the device that helps measure or monitor the amount of medication being administered. It also mentions a "Barrel Plunger" which is likely a component of the device, possibly used to deliver or extract medication. Lastly, it notes a "Black ring on plunger", potentially indicating a specific marker or measurement point on the plunger. Overall, this description suggests that this device is intended for precise dosing of medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.